AJP - Renal Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 295: F758-F764, 2008. First published July 2, 2008; doi:10.1152/ajprenal.90291.2008
0363-6127/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/3/F758    most recent
90291.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haque, M. Z.
Right arrow Articles by Majid, D. S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haque, M. Z.
Right arrow Articles by Majid, D. S. A.

Reduced renal responses to nitric oxide synthase inhibition in mice lacking the gene for gp91phox subunit of NAD(P)H oxidase

Mohammed Z. Haque and Dewan S. A. Majid

Department of Physiology, Hypertension and Renal Center of Excellence, Tulane University Health Sciences Center, New Orleans, Louisiana

Submitted 13 May 2008 ; accepted in final form 29 June 2008

Both short-term and long-term nitric oxide (NO) blockade were shown to cause an increase in O2 activity. To assess the contribution of such enhanced O2 activity in the kidney, responses to administration of the NO synthase inhibitor nitro-L-arginine methyl ester (L-NAME; 200 µg·min–1·kg body wt–1) were assessed in knockout mice the lacking NAD(P)H oxidase subunit gp91phox (KO; n = 10) and in wild-type (WT; n = 10) mice. Renal blood flow (RBF) and glomerular filtration rate (GFR) were determined by PAH and inulin clearances, respectively. Baseline RBF was higher in KO compared with WT mice (5.8 ± 0.5 vs. 4.5 ± 0.3 ml·min–1·g–1; P < 0.04) without significant differences in GFR (0.62 ± 0.04 vs. 0.73 ± 0.05 ml·min–1·g–1) and in mean arterial pressure (MAP; 91 ± 6 vs. 88 ± 4 mmHg). L-NAME infusion for 60 min caused similar increases in MAP (114 ± 6 vs. 113 ± 3 mmHg) in both groups but resulted in a lesser degree of reduction in RBF in KO compared with WT mice (–7 ± 3 vs. –17 ± 3%; P < 0.02), although GFR remained unchanged in both groups. The natriuretic response to systemic L-NAME infusion was attenuated in KO compared with WT mice ({Delta}: 3.1 ± 0.7 vs. 5.2 ± 0.6 µmol·min–1·g–1). L-NAME increased urinary 8-isoprostane excretion rate in WT (5.9 ± 1 to 7.7 ± 1 pg·min–1·g–1; P < 0.02) but not in KO mice (5.6 ± 1 to 4.9 ± 0.3 pg·min–1·g–1). In contrast, responses to another vasoconstrictor, norepinephrine, were similar in both strains of mice. These data indicate that activation of NAD(P)H oxidase results in the enhancement of O2 activity that influences renal hemodynamics and excretory function in the condition of NO deficiency.

superoxide; oxidative stress; renal blood flow; sodium excretion; 8-isoprostane excretion



Address for reprint requests and other correspondence: D. S. A. Majid, Dept. of Physiology (SL 39), Hypertension and Renal Center of Excellence, Tulane Univ. Health Sciences Center, 1430 Tulane Ave., New Orleans, LA 70112 (e-mail: majid{at}tulane.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.